Press Release Archive

Welcome to the press release archive for the ECOG-ACRIN Cancer Research Group. This section of the website provides a comprehensive listing of past press releases in a central location, ordered by date.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


May 11, 2023
May 11, 2023
Categories

Press Release: Historic achievement for the ongoing InPACT penile cancer trial—100 patients enrolled thus far, the most ever to a prospective study in this extremely rare disease

Do you like it?
Read more
December 13, 2022
December 13, 2022
Categories

Press Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)

Do you like it?
Read more
December 11, 2022
December 11, 2022
Categories

Press Release: A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressive—yet highly curable—acute promyelocytic leukemia (APL)

Do you like it?
Read more
December 6, 2022
December 6, 2022
Categories

Press Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes

Do you like it?
Read more
October 28, 2022
October 28, 2022
Categories

Press Release: NCI Director Monica Bertagnolli delivers her first public speech at the ECOG-ACRIN Cancer Research Group meeting

Do you like it?
Read more
October 26, 2022
October 26, 2022
Categories

Press Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib

Do you like it?
Read more
October 21, 2022
October 21, 2022
Categories

Press Release: Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting to assess the stage of disease more accurately using standard CT scans

Do you like it?
Read more
October 20, 2022
October 20, 2022
Categories

Press Release: ECOG-ACRIN taps the University of Pennsylvania’s Selina Luger to lead its Leukemia Committee

Do you like it?
Read more
September 27, 2022
September 27, 2022
Categories

Media Advisory: Journal of Clinical Oncology publishes outcomes from the practice-changing DREAMseq trial in patients with advanced melanoma

Do you like it?
Read more
September 8, 2022
September 8, 2022
Categories

Press Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

Do you like it?
Read more
July 14, 2022
July 14, 2022
Categories

Media Advisory: Blood publishes long-term outcomes of patients with CLL in the practice-changing E1912 trial

Do you like it?
Read more
May 27, 2022
May 27, 2022
Categories

Press Release: ECOG-ACRIN research highlights at ASCO 2022

Do you like it?
Read more
May 17, 2022
May 17, 2022
Categories

Media Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio

Do you like it?
Read more
March 25, 2022
March 25, 2022
Categories

Press Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success

Do you like it?
Read more
March 16, 2022
March 16, 2022
Categories

Press Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

Do you like it?
Read more
December 21, 2021
December 21, 2021
Categories

Press Release: A new post-surgery approach for treating HPV-related throat cancer uses less radiation safely and spares the majority of patients from chemotherapy

Do you like it?
Read more
November 16, 2021
November 16, 2021
Categories

Press Release: Practice-changing trial results for advanced skin cancer

Do you like it?
Read more
November 15, 2021
November 15, 2021
Categories

Press Release: Mitchell D. Schnall re-elected as Group Co-Chair of the ECOG-ACRIN Cancer Research Group

Do you like it?
Read more
October 6, 2021
October 6, 2021
Categories

Press Release: Chronic stress is linked to poor breast cancer outcomes

Do you like it?
Read more
April 26, 2021
April 26, 2021
Categories

Press Release: 12 open arms in NCI-MATCH treatment trial await patients with advanced or rare cancers

Do you like it?
Read more
Load more
Press Release Archive

About Us Home Page

Press Release Archive
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Bladder cancer Breast cancer Cancer screening Cancer treatment Care delivery Clinical trial ComboMATCH Disparities Diversity Gallbladder cancer Gastric cancer Gene testing GI cancer Group meeting Head and neck cancer Health equity Immunotherapy In memory Kidney cancer Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma Myelodysplastic syndrome (MDS) NCI-MATCH Pancreatic cancer Personalized screening Personalized treatment Precision medicine Precision oncology Prostate cancer Real world data Research results Sarcoma Skin cancer Social determinants of health (SDoH) Survivorship TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group